Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-Lowering Therapies for Three Acute Outcomes
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-33483-y
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 11, 2018
Authors
Publisher
Springer Science and Business Media LLC